NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Nutex Health Inc. investors who were adversely affected by alleged securities fraud between August 8, 2024 and August 14, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/nutex- ...

Accessibility StatementSkip Navigation NEW YORK, Sept. 18, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX) and reminds investors of the October 21, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. James (Josh) Wilson, Faruqi & Faruqi Senior Partner (PRNewsfoto/Faruqi & Faruqi, LLP) Faruqi & Faruq ...

NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX). Shareholders who purchased shares of NUTX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/nutex-health-inc-loss-submission-form/?id=167848&from=3 CLASS PERIOD: August 8, ...

NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class Period”), of the important October 21, 2025 lead plaintiff deadline. SO WHAT: If you purchased Nutex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WH ...

NEW YORK , Sept. 18, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX). ...

Nutex Health Inc. (NASDAQ:NUTX) is set to release its quarterly earnings with an anticipated EPS of -$5.43 and projected revenue of $210.89 million.The company is currently facing a class-action lawsuit over deceptive billing practices, potentially impacting its financial outlook.Despite legal challenges, NUTX's has a price-to-sales ratio of 0.80 suggest it may be undervalued.Nutex Health Inc. (NASDAQ:NUTX), a prominent healthcare company that operates micro-hospitals and healthcare facilities, is gearing u ...

NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Nutex Health Inc. investors who were adversely affected by alleged securities fraud between August 8, 2024 and August 14, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/nutex- ...

Accessibility StatementSkip Navigation https://zlk.com/pslra-1/nutex-health-inc-lawsuit-submission-form?prid=167310&wire=4 NUTX investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) HaloMD, a third-party IDR vendor, was achieving lucrative arbitration results for Nutex by engaging in a coordinated scheme to defraud insurance companies; (ii ...

NEW YORK , Sept. 15, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX). ...

核心诉讼指控 - 公司面临集体诉讼 指控其与第三方计费公司HaloMD合谋提交不符合资格的保险索赔 通过仲裁程序获取超额报销 人为提升财务表现[1][2] - 诉讼称公司收入模式建立在不可持续的基础上 数千份可疑索赔被虚假认证 仲裁驱动型收入缺乏长期可行性[2] - 公司被指控在2024年8月8日至2025年8月14日期间误导投资者 导致重大损失[2][9] 做空报告影响 - 做空机构Blue Orca Capital于2025年7月22日发布报告 指控HaloMD实施"欺诈计划"从保险公司转移数百万美元资金[3] - 报告引用Anthem和Blue Cross Blue Shield附属公司提起的诉讼 称HaloMD用无效索赔淹没仲裁系统[3] - Blue Orca警告公司对仲裁报销的依赖存在重大风险 股价可能跌至仙股水平 报告发布后股价下跌超过10%[4] 财务报告问题 - 公司被指控错误分类股票薪酬义务 将其视为股权而非负债 扭曲真实财务状[5] - 审计委员会发现医院开发相关义务存在错误分类 需对先前财务报表进行重述[7] - 公司于8月14日延迟提交10-Q表格 提及"非现金会计调整" 次日股价暴跌16.39%至92.91美元[6] 公司回应与市场反应 - 公司于7月24日否认Blue Orca指控 承诺在季度文件中澄清 但未直接回应核心指控[6][8] - 公司强调未在针对HaloMD的诉讼中被点名 但批评者认为这回避了实质问题[8] - 法律调查重点关注公司商业模式是否基于可疑仲裁策略以及财务报告是否误导投资者[10]